Finland transfers medtech regulation duty to medicines regulator
The duty of supervising medical devices, device trials and operators in Finland has been transferred from the National Supervisory Authority for Welfare and Health to the Finnish Medicines Agency, Fimea. The transfer is intended "to concentrate expertise related to the quality, efficacy and safety of medicines and devices, and to gain synergy benefits as a result," Fimea stated. Regulatory Focus (1/6)
Read full article now.
Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!